Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C R Stiller

Showing results (131-140 of 141) with videos related to

Pageof 15
Sort By:
Transplantation Proceedings|June 1, 1988
Effects of immunosuppression with cyclosporine in insulin-dependent diabetes mellitus of recent onset: the Canadian open study at 44 monthsJ Dupré, C R Stiller, M Gent, et al.
The Journal of Pediatrics|December 1, 1987
Effects of cyclosporine in recent-onset juvenile type 1 diabetes: impact of age and duration of diseaseC R Stiller, J Dupre, M Gent, et al.
Lancet (London, England)|November 8, 1986
Immunosuppressive drugs in diabetesR Assan, J F Bach, P Czernichow, et al.
Transplantation Proceedings|December 1, 1985
Organ retrieval and distributionP A Keown, G S Arbus, R C Bennett, et al.
Science (New York, N.Y.)|March 30, 1984
Effects of cyclosporine immunosuppression in insulin-dependent diabetes mellitus of recent onsetC R Stiller, J Dupré, M Gent, et al.
Diabetes Care|March 1, 1996
Continued insulin dependence despite normal range insulin sensitivity and insulin connecting peptide levels in a kidney/islet transplant patientP R Atkison, P Zucker, I Hramiak, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1993
Human mouse chimeric CD7 monoclonal antibody (SDZCHH380) for the prophylaxis of kidney transplant rejectionA I Lazarovits, J Rochon, L Banks, et al.
Transplantation Proceedings|February 1, 1993
Human mouse chimeric CD7 monoclonal antibody (SDZCHH380) for the prophylaxis of kidney transplant rejectionA I Lazarovits, J Rochon, L Banks, et al.
Journal of Clinical Pharmacology|March 20, 1998
Phase I safety and pharmacokinetic studies of brequinar sodium after single ascending oral doses in stable renal, hepatic, and cardiac allograft recipientsA S Joshi, S Y King, B A Zajac, et al.
Nature|April 25, 1996
Prevention and reversal of renal allograft rejection by antibody against CD45RBA I Lazarovits, S Poppema, Z Zhang, et al.
Pageof 15

Showing results (131-140 of 141) with videos related to

Sort By:
Pageof 15
Transplantation Proceedings|June 1, 1988
Effects of immunosuppression with cyclosporine in insulin-dependent diabetes mellitus of recent onset: the Canadian open study at 44 monthsJ Dupré, C R Stiller, M Gent, et al.
The Journal of Pediatrics|December 1, 1987
Effects of cyclosporine in recent-onset juvenile type 1 diabetes: impact of age and duration of diseaseC R Stiller, J Dupre, M Gent, et al.
Lancet (London, England)|November 8, 1986
Immunosuppressive drugs in diabetesR Assan, J F Bach, P Czernichow, et al.
Transplantation Proceedings|December 1, 1985
Organ retrieval and distributionP A Keown, G S Arbus, R C Bennett, et al.
Science (New York, N.Y.)|March 30, 1984
Effects of cyclosporine immunosuppression in insulin-dependent diabetes mellitus of recent onsetC R Stiller, J Dupré, M Gent, et al.
Diabetes Care|March 1, 1996
Continued insulin dependence despite normal range insulin sensitivity and insulin connecting peptide levels in a kidney/islet transplant patientP R Atkison, P Zucker, I Hramiak, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1993
Human mouse chimeric CD7 monoclonal antibody (SDZCHH380) for the prophylaxis of kidney transplant rejectionA I Lazarovits, J Rochon, L Banks, et al.
Transplantation Proceedings|February 1, 1993
Human mouse chimeric CD7 monoclonal antibody (SDZCHH380) for the prophylaxis of kidney transplant rejectionA I Lazarovits, J Rochon, L Banks, et al.
Journal of Clinical Pharmacology|March 20, 1998
Phase I safety and pharmacokinetic studies of brequinar sodium after single ascending oral doses in stable renal, hepatic, and cardiac allograft recipientsA S Joshi, S Y King, B A Zajac, et al.
Nature|April 25, 1996
Prevention and reversal of renal allograft rejection by antibody against CD45RBA I Lazarovits, S Poppema, Z Zhang, et al.
Pageof 15